Friday, October 9, 2026
The top medical stories of the day, as they ran.
Morning edition
12 stories
- 1WHO seeks answers after Russian lab worker dies with pneumoniaInfectious disease · 4 outlets
- 2FDA expects mifepristone safety review report by March 2027Drugs and FDA · 4 outlets
- 3Argenx reports Sjögren’s trial setback and celiac disease successResearch · 4 outlets
- 4HHS opens NIH clinic to study vaccine injuriesVaccines · 3 outlets
- 5Gardeners Basics recalls broccoli sprouting seeds over possible SalmonellaFood safety · 1 outlet
- 6Haleon recalls eight lots of Robitussin Honey CF Max cough syrupRecalls · 1 outlet
- 7CooperSurgical recalls INCA infant CPAP sets over loose connectionsMedical devices · 1 outlet
- 8Endeavor reports phase 2b success for potential IPF drugResearch · 2 outlets
- 9Pallone proposes replacing No Surprises Act arbitration processHealth policy · 2 outlets
- 10Zealand and Roche report phase 2 results for petrelintideDrugs and FDA · 2 outlets
- 11FDA approves atezolizumab combinations for Stage III dMMR colon cancerDrugs and FDA · 1 outlet
- 12Study finds maternal flu associations did not persist in sibling analysesResearch · 2 outlets
Evening edition
17 stories
- 1HHS launches initiatives to study vaccine injuries and strengthen reportingPublic health · 5 outlets
- 2Pallone proposes replacing No Surprises Act arbitration with payment benchmarksInsurance · 3 outlets
- 3Russia faces questions over reporting lab worker’s death to WHOInfectious disease · 3 outlets
- 4CMS releases 2027 Medicare Advantage star ratingsMedicare and Medicaid · 3 outlets
- 5Fonagy review calls for needs-led mental health and neurodevelopmental supportMental health · 4 outlets
- 6FDA approves pritelivir for herpes lesions in immunocompromised adultsDrugs and FDA · 3 outlets
- 7FDA approves atezolizumab and chemotherapy for stage III dMMR colon cancerDrugs and FDA · 3 outlets
- 8Three Colorado patients reported symptoms after injections of unapproved toxinDrug safety · 2 outlets
- 9Argenx reports Sjögren’s trial setback and celiac disease successResearch · 3 outlets
- 10NIH plans public-private initiative to speed personalized cancer vaccinesResearch · 3 outlets
- 11Utah expands AI prescription pilot as physician groups call for reevaluationHealth policy · 3 outlets
- 12FDA flags potential safety signal for investigational schizophrenia drugDrug safety · 1 outlet
- 13Life Biosciences reports early vision changes in glaucoma therapy trialResearch · 2 outlets
- 14FDA documents show Rasonque responses varied by pancreatic cancer mutationDrugs and FDA · 2 outlets
- 15NHS leaders warn winter pressures are already building in England's hospitalsHospitals · 2 outlets
- 16Forescout finds healthcare systems underprepared for quantum threatsResearch · 2 outlets
- 17Trial finds community program reduced BMI z-scores in childrenPediatrics · 2 outlets